137 related articles for article (PubMed ID: 26995512)
1. A novel minimal residual disease model of neuroblastoma in mice.
Jackson JR; Kim Y; Seeger RC; Kim ES
J Pediatr Surg; 2016 Jun; 51(6):991-4. PubMed ID: 26995512
[TBL] [Abstract][Full Text] [Related]
2. Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.
Zobel MJ; Zamora AK; Wu HW; Sun J; Lascano D; Malvar J; Wang L; Sheard MA; Seeger RC; Kim ES
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428582
[TBL] [Abstract][Full Text] [Related]
3. Tissue-directed Implantation Using Ultrasound Visualization for Development of Biologically Relevant Metastatic Tumor Xenografts.
VAN Noord RA; Thomas T; Krook M; Chukkapalli S; Hoenerhoff MJ; Dillman JR; Lawlor ER; Opipari VP; Newman EA
In Vivo; 2017; 31(5):779-791. PubMed ID: 28882943
[TBL] [Abstract][Full Text] [Related]
4. Anti-relapse effect of trametinib on a local minimal residual disease neuroblastoma mouse model.
Togashi Y; Tanaka T; Takemoto M; Takeuchi Y; Higashi M; Fumino S; Tajiri T
J Pediatr Surg; 2021 Jul; 56(7):1233-1239. PubMed ID: 33863557
[TBL] [Abstract][Full Text] [Related]
5. Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma.
Cheung IY; Feng Y; Cheung NK
Pediatr Blood Cancer; 2013 Jul; 60(7):E32-4. PubMed ID: 23335404
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells.
Hartomo TB; Kozaki A; Hasegawa D; Van Huyen Pham T; Yamamoto N; Saitoh A; Ishida T; Kawasaki K; Kosaka Y; Ohashi H; Yamamoto T; Morikawa S; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Iijima K; Matsuo M; Nishio H; Nishimura N
Oncol Rep; 2013 Apr; 29(4):1629-36. PubMed ID: 23417100
[TBL] [Abstract][Full Text] [Related]
7. Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma.
Bochennek K; Esser R; Lehrnbecher T; Glienke W; Wehner S; Erben S; Soerensen J; Schwabe D; Bader P; Klingebiel T; Koehl U
Klin Padiatr; 2012 Apr; 224(3):139-42. PubMed ID: 22377741
[TBL] [Abstract][Full Text] [Related]
8. Enhanced metastatic growth after local tumor resection in the presence of synchronous metastasis in a mouse allograft model of neuroblastoma.
Inoue M; Tsuchiya Y; Koike N; Umemura Y; Inokawa H; Togashi Y; Maniwa J; Higashi M; Fumino S; Tajiri T; Yagita K
Pediatr Surg Int; 2019 Dec; 35(12):1403-1411. PubMed ID: 31555858
[TBL] [Abstract][Full Text] [Related]
9. Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.
Lascano D; Zobel MJ; Lee WG; Chen SY; Zamora A; Asuelime GE; Choi SY; Chronopoulos A; Asgharzadeh S; Marachelian A; Park J; Sheard MA; Kim ES
Sci Rep; 2023 Nov; 13(1):19915. PubMed ID: 37964011
[TBL] [Abstract][Full Text] [Related]
10. Very long-term molecular follow-up of minimal residual disease in patients with neuroblastoma.
Tchirkov A; Greze V; Plantaz D; Rouel N; Vago P; Kanold J
Pediatr Blood Cancer; 2018 Dec; 65(12):e27404. PubMed ID: 30216652
[TBL] [Abstract][Full Text] [Related]
11. The role of surgery in stage IV neuroblastoma.
Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
[TBL] [Abstract][Full Text] [Related]
12. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Vorotnjak M; Boos J; Lanvers-Kaminsky C
Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
[TBL] [Abstract][Full Text] [Related]
13. Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice.
Harris J; Herrero-Garcia E; Russo A; Kajdacsy-Balla A; O'Bryan JP; Chiu B
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e413-e418. PubMed ID: 28787396
[TBL] [Abstract][Full Text] [Related]
14. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
[TBL] [Abstract][Full Text] [Related]
15. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
Fukuda M; Miyajima Y; Miyashita Y; Horibe K
J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
17. Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma.
Koh CC; Sheu JC; Liang DC; Chen SH; Liu HC
Pediatr Surg Int; 2005 Feb; 21(2):69-72. PubMed ID: 15647910
[TBL] [Abstract][Full Text] [Related]
18. The effect of complete excision on stage III neuroblastoma: a report of the European Neuroblastoma Study Group.
Powis MR; Imeson JD; Holmes SJ
J Pediatr Surg; 1996 Apr; 31(4):516-9. PubMed ID: 8801303
[TBL] [Abstract][Full Text] [Related]
19. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement.
Ferris MJ; Danish H; Switchenko JM; Deng C; George BA; Goldsmith KC; Wasilewski KJ; Cash WT; Khan MK; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):806-812. PubMed ID: 28244417
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
